相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank
Qiao Jin et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)
Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation
Mitsuhiro Kunimoto et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes
Henderikus E. Boersma et al.
BMC ENDOCRINE DISORDERS (2021)
Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank
Qiao Jin et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations
Saad Rojubally et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
Factors Associated With Change in Skin Autofluorescence, a Measure of Advanced Glycation End Products, in Persons Receiving Dialysis
Daniela Viramontes Horner et al.
KIDNEY INTERNATIONAL REPORTS (2020)
The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study
Adam Shardlow et al.
PLOS MEDICINE (2020)
Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population
Robert P. van Waateringe et al.
DIABETOLOGIA (2019)
Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study
C. Blanc-Bisson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus
K. Yozgatli et al.
DIABETIC MEDICINE (2018)
Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant
Jesus Calvino et al.
PLOS ONE (2018)
Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study
B. T. Fokkens et al.
DIABETES & METABOLISM (2018)
Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study
Enric Sanchez et al.
PLOS ONE (2017)
Skin Autofluorescence Is a Predictor of Cardiovascular Disease in Chronic Kidney Disease Patients
Fumihiko Furuya et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2015)
Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review
Stefan Arsov et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Skin Autofluorescence and All-Cause Mortality in Stage 3 CKD
Simon D. S. Fraser et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Tissue Advanced Glycation End Product Deposition after Kidney Transplantation
Lisa E. Crowley et al.
NEPHRON CLINICAL PRACTICE (2013)
Skin Autofluorescence and the Association with Renal and Cardiovascular Risk Factors in Chronic Kidney Disease Stage 3
Natasha J. McIntyre et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus
H. L. Lutgers et al.
DIABETOLOGIA (2009)
Skin autofluorescence - A tool to identify type 2 diabetic patients at risk for developing microvascular complications
Esther G. Gerrits et al.
DIABETES CARE (2008)
Simple non-invasive assessment of advanced glycation endproduct accumulation
R Meerwaldt et al.
DIABETOLOGIA (2004)
分享论文
